ContraFect Announces Third Quarter 2018 Financial Results
YONKERS, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Opera Limited announces third quarter 2018 financial results and initiation of share repurchase program
Revenue of $44.7 million, with 56.8% year-over-year growth of advertising revenue All-time-high operating profit, net income, adjusted EBITDA and adjusted […]
Assembly Biosciences Announces Third Quarter 2018 Financial Results and Provides HBV Program Update
ABI-H0731 Phase 2a Clinical Trials Actively Enrolling Patients; Data Continues to be Anticipated in 1H 2019 ABI-H2158 Phase 1a Study […]
AAON Announces Semi-Annual Cash Dividend
TULSA, Okla., Nov. 08, 2018 (GLOBE NEWSWIRE) — AAON, Inc. (NASDAQ-AAON), today announced that its Board of Directors has declared […]
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress
— U.S. Food and Drug Administration Accepts Karyopharm’s New Drug Application for Selinexor and Grants Priority Review; Assigns PDUFA Action […]
Corbus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
Licensed Jenrin Discovery’s extensive library of small molecules targeting the endocannabinoid system (ECS) positioning Corbus with the leading pipeline focused […]
Pluristem Therapeutics Reports Fiscal 2019 First Quarter Results and Provides Corporate Update
HAIFA, Israel, Nov. 08, 2018 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel […]
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company […]
Anavex Life Sciences Strengthens its Scientific Advisory Board with Distinguished Researcher for Clinical Treatment of Parkinson’s Disease Dementia (PDD)
NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]
Lifetime Brands, Inc. Reports Third Quarter Financial Results
Results Demonstrate that Benefits of Filament Merger Are on TrackInitiatives Successfully Positioning Lifetime for Long Term ProfitabilityDeclares Regular Quarterly Dividend […]
